DURABILITY OF THE EFFECTS OF TESTOSTERONE AND GROWTH HORMONE SUPPLEMENTATION
睾酮和生长激素补充剂效果的持久性
基本信息
- 批准号:8361472
- 负责人:
- 金额:$ 0.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse eventBody CompositionCommunitiesDEXAFundingGelGrantInsulin-Like Growth Factor IMasksMass Spectrum AnalysisMeasurementNational Center for Research ResourcesParticipantPrincipal InvestigatorQuality of lifeQuestionnairesRandomized Controlled TrialsResearchResearch InfrastructureResourcesSomatotropinSourceSupplementationTestingTestosteroneUnited States National Institutes of Healthbiomedical resourcecostdesignfollow-upolder menr-hGH-M
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Objectives: Determine the durability of anabolic effects and adverse events (AEs) after stopping testosterone and growth hormone supplementation in older men. Design: Double-masked, randomized controlled trial (2X3 factorial design) to test testosterone gel (5g or 10g/daily) and rhGH (0, 3, or 5ug/kg/day) for 16-weeks with follow-up 3-months later. Participants: 108 community-dwelling 65-90 year-old-men. Measurements: Testosterone and IGF-1 levels, body composition (DEXA), 1-repetition maximum (1-RM) strength, stair-climbing power, quality-of-life (QOL) and activity questionnaires, AEs.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其它NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
目的:确定老年男性停止睾酮和生长激素补充后合成代谢作用和不良事件(AE)的持久性。设计图:双盲、随机对照试验(2X 3析因设计),测试睾酮凝胶(5g或10 g/天)和rhGH(0、3或5 ug/kg/天),持续16周,3个月后随访。参与者:108名居住在社区的65-90岁男性。测量值:睾酮和IGF-1水平、身体组成(DEXA)、1次重复最大(1-RM)力量、爬楼梯能力、生活质量(QOL)和活动问卷、AE。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRED R SATTLER其他文献
FRED R SATTLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRED R SATTLER', 18)}}的其他基金
TESTOSTERONE THRESHOLD LEVELS AND LEAN TISSUE MASS TARGETS NEEDED
所需的睾酮阈值水平和瘦肉组织质量目标
- 批准号:
8361473 - 财政年份:2011
- 资助金额:
$ 0.81万 - 项目类别:
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND
睾酮和生长激素改善身体成分
- 批准号:
8361388 - 财政年份:2011
- 资助金额:
$ 0.81万 - 项目类别:
WHOLE BODY AND MUSCLE PROTEIN METABOLISM ARE NOT AFFECTED BY ACUTE DEVIATIONS
全身和肌肉蛋白质代谢不受急性偏差的影响
- 批准号:
8361467 - 财政年份:2011
- 资助金额:
$ 0.81万 - 项目类别:
EVALUATION OF HIGH-PROTEIN SUPPLEMENTATION IN WEIGHT-STABLE HIV-POSITIVE
体重稳定的 HIV 阳性患者的高蛋白补充评估
- 批准号:
8168764 - 财政年份:2010
- 资助金额:
$ 0.81万 - 项目类别:
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND
睾酮和生长激素改善身体成分
- 批准号:
8168784 - 财政年份:2010
- 资助金额:
$ 0.81万 - 项目类别:
EVALUATION OF HIGH-PROTEIN SUPPLEMENTATION IN WEIGHT-STABLE HIV-POSITIVE
体重稳定的 HIV 阳性患者的高蛋白补充评估
- 批准号:
7954017 - 财政年份:2009
- 资助金额:
$ 0.81万 - 项目类别:
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND
睾酮和生长激素改善身体成分
- 批准号:
7954033 - 财政年份:2009
- 资助金额:
$ 0.81万 - 项目类别:
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA
研究人员开始研究雄激素治疗对碳水化合物的影响
- 批准号:
7982111 - 财政年份:2008
- 资助金额:
$ 0.81万 - 项目类别:
A PHASE II/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URIDINE
尿苷 II/III 期、随机、双盲、安慰剂对照试验
- 批准号:
7982124 - 财政年份:2008
- 资助金额:
$ 0.81万 - 项目类别:
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING (HORMA)--1 R01 AG18169-01
衰老过程中肌肉和新陈代谢的激素调节剂 (HORMA)--1 R01 AG18169-01
- 批准号:
7716680 - 财政年份:2008
- 资助金额:
$ 0.81万 - 项目类别:
相似海外基金
Understanding causes and consequences of variation in body composition, cardiorespiratory and muscular fitness
了解身体成分、心肺和肌肉健康变化的原因和后果
- 批准号:
MR/Y009398/1 - 财政年份:2024
- 资助金额:
$ 0.81万 - 项目类别:
Fellowship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Effects of daily low oxygen exposure on weight status, body composition, and metabolic health
每日低氧暴露对体重状况、身体成分和代谢健康的影响
- 批准号:
10756039 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
- 批准号:
22KJ2600 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Differential impacts of water insecurity on diet and body composition throughout the life course
水不安全对整个生命过程中饮食和身体成分的不同影响
- 批准号:
10749236 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Oral Feeding Difficulty in Large for Gestational Age Infants: Defining Interrelationships between Body Composition, Oral Feeding Ability, and Appetite-Regulating Hormones
大胎龄婴儿的经口喂养困难:定义身体成分、经口喂养能力和食欲调节激素之间的相互关系
- 批准号:
10734263 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Staging the host in Cancer: AI-based automated comprehensive body composition assessment for Precision Medicine
对癌症宿主进行分期:基于人工智能的自动化综合身体成分评估,用于精准医学
- 批准号:
478392 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Operating Grants
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity
bimagrumab 对肥胖成人的身体成分、胰岛素敏感性和骨骼的影响
- 批准号:
10716254 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:
Relating phthalate and metals exposure during pregnancy and perimenopause to bone health and body composition in midlife
怀孕和围绝经期期间邻苯二甲酸盐和金属暴露与中年骨骼健康和身体成分的关系
- 批准号:
10746972 - 财政年份:2023
- 资助金额:
$ 0.81万 - 项目类别:














{{item.name}}会员




